" class="no-js "lang="en-US"> Caleb Bell - Medtech Alert
Saturday, March 25, 2023

Breaking News

Illumina and GenoScreen Launch Next Generation Sequencing Innovation to Eliminate Tuberculosis in Africa Celyad Oncology Appoints Georges Rawadi as Its New CEO Companion Spine Closes $60.1 Million Series A Funding Round EVERSANA® Announces Partnership with ChemoMouthpiece, LLC to Support U.S. Launch & Commercialization of Medical Device to Help Cancer Patients Manage and Treat Oral Mucositis Vividion Therapeutics Promotes Matt Patricelli to Chief Scientific Officer GT Medical Technologies Raises $45 Million in Oversubscribed Series C Financing Led by Gilde Healthcare Genprex CEO Commends FDA’s Initiative to Accelerate Approval Process for Gene Therapies OliX Pharmaceuticals Receives Regulatory Approval to Commence Phase 1 Clinical Trial of Treatment of Androgenic Alopecia Bayer Expands Global Clinical Program for NUBEQA® (darolutamide) in Prostate Cancer BIOTECanada Welcomes Government of Canada’s Strategy on Improving Access to Care for Patients with Rare Diseases
Caleb Bell

Caleb Bell

About Caleb Bell

Eternally curious student of life that is looking to help bio-technologies eat the world and bring about a renaissance where commercial and industrial advancements are in synergy with Nature and improving all of society.

Related Story

Diseases

 Elevian Raises $40 Million Series A to Advance Treatments for Stroke Recovery and Age-Related Diseases | Pharmtech Focus

Elevian Raises $40 Million Series A to Advance Treatments for Stroke Recovery and Age-Related Diseases

September 17 2021

Elevian, an emerging biotech company developing medicines that restore youthful regenerative capacity with the potential […]